Publications:

Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer.

Oncoimmunology

Giroux Leprieur, Etienne E; Herbretau, Guillaume G; Dumenil, Coraline C; Julie, Catherine C; Giraud, Violaine V; Labrune, Sylvie S; Dumoulin, Jennifer J; Tisserand, Julie J; Emile, Jean-François JF; Blons, Hélène H; Chinet, Thierry T

Publication Date: 2018

Variant appearance in text: TP53: Ser269_Phe270del

PubMed Link: 29721388

Variant Present in the following documents:

• Main text

View BVdb publication page